
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18582833
[patent_doc_number] => 20230265088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => The Method of the Preparation of Fused Multicyclic Compounds
[patent_app_type] => utility
[patent_app_number] => 17/651769
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651769 | Method of the preparation of fused multicyclic compounds | Feb 17, 2022 | Issued |
Array
(
[id] => 19202739
[patent_doc_number] => 20240174638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => HETEROARYL DERIVATIVES AS APELIN RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/278656
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278656 | HETEROARYL DERIVATIVES AS APELIN RECEPTOR AGONISTS | Feb 14, 2022 | Pending |
Array
(
[id] => 17641873
[patent_doc_number] => 20220169611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/672660
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672660 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | Feb 14, 2022 | Abandoned |
Array
(
[id] => 19556358
[patent_doc_number] => 20240368150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/546087
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546087 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | Feb 9, 2022 | Pending |
Array
(
[id] => 19172411
[patent_doc_number] => 20240158385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => NOVEL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/275862
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275862
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275862 | NOVEL COMPOUNDS | Feb 7, 2022 | Pending |
Array
(
[id] => 17953450
[patent_doc_number] => 11479541
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-25
[patent_title] => Acid addition salts, compositions, and methods of treating thereof
[patent_app_type] => utility
[patent_app_number] => 17/588847
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5372
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588847 | Acid addition salts, compositions, and methods of treating thereof | Jan 30, 2022 | Issued |
Array
(
[id] => 19127129
[patent_doc_number] => 20240132482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => BENZO SEVEN-MEMBERED RING BIFUNCTIONAL COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/274674
[patent_app_country] => US
[patent_app_date] => 2022-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274674 | BENZO SEVEN-MEMBERED RING BIFUNCTIONAL COMPOUND AND APPLICATION THEREOF | Jan 28, 2022 | Pending |
Array
(
[id] => 19187697
[patent_doc_number] => 20240166610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/263702
[patent_app_country] => US
[patent_app_date] => 2022-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263702 | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES | Jan 28, 2022 | Pending |
Array
(
[id] => 19127105
[patent_doc_number] => 20240132458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/275470
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275470 | NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE | Jan 27, 2022 | Pending |
Array
(
[id] => 19464063
[patent_doc_number] => 20240317732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13
[patent_app_type] => utility
[patent_app_number] => 18/262941
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262941 | A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13 | Jan 27, 2022 | Pending |
Array
(
[id] => 17611476
[patent_doc_number] => 20220153755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NMDA RECEPTOR MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/585849
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585849
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585849 | NMDA receptor modulators and uses thereof | Jan 26, 2022 | Issued |
Array
(
[id] => 19142138
[patent_doc_number] => 20240140962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => 5,6-DIHYDROTHIENO[3,4-H]QUINAZOLINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/276226
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276226
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276226 | 5,6-dihydrothieno[3,4-h]quinazoline compound | Jan 25, 2022 | Issued |
Array
(
[id] => 19157628
[patent_doc_number] => 20240150335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => FUSED RING DERIVATIVES CONTAINING 1,4-OXAZEPANE
[patent_app_type] => utility
[patent_app_number] => 18/275706
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275706
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275706 | FUSED RING DERIVATIVES CONTAINING 1,4-OXAZEPANE | Jan 25, 2022 | Pending |
Array
(
[id] => 20578405
[patent_doc_number] => 12570647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Amino benzothiazole compounds for treatment of antibiotic resistant bacteria
[patent_app_type] => utility
[patent_app_number] => 17/578616
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19070
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578616 | Amino benzothiazole compounds for treatment of antibiotic resistant bacteria | Jan 18, 2022 | Issued |
Array
(
[id] => 18748352
[patent_doc_number] => 11807648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Process for preparing substituted polycyclic pyridone derivative and crystal thereof
[patent_app_type] => utility
[patent_app_number] => 17/578743
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 13325
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578743 | Process for preparing substituted polycyclic pyridone derivative and crystal thereof | Jan 18, 2022 | Issued |
Array
(
[id] => 18102397
[patent_doc_number] => 11542272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Five-membered heteroaryl-fused imidazole compound and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/574817
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20174
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574817 | Five-membered heteroaryl-fused imidazole compound and application thereof | Jan 12, 2022 | Issued |
Array
(
[id] => 19651220
[patent_doc_number] => 12172988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Anticancer and antifungal splice modulators
[patent_app_type] => utility
[patent_app_number] => 17/574100
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 38
[patent_no_of_words] => 41281
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574100 | Anticancer and antifungal splice modulators | Jan 11, 2022 | Issued |
Array
(
[id] => 17563133
[patent_doc_number] => 20220127282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/569367
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569367 | Compounds useful to treat influenza virus infections | Jan 4, 2022 | Issued |
Array
(
[id] => 17563108
[patent_doc_number] => 20220127257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => SMALL MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/567280
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/567280 | SMALL MOLECULES | Jan 2, 2022 | Abandoned |
Array
(
[id] => 19083064
[patent_doc_number] => 20240109865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => INDAZOLE COMPOUNDS AS KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/259422
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259422 | Indazole compounds as kinase inhibitors | Dec 29, 2021 | Issued |